Day: October 1, 2024

ExxonMobil Announces Launch of Signature Polymers

A new portfolio brand focused on delivering best-in-class service and partnership in the polymers industry SPRING, Texas, Oct. 01, 2024 (GLOBE NEWSWIRE) —  ExxonMobil today announces the introduction of Signature Polymers, a new approach to service and partnership with customers and the broader value chain. The stated brand ambition of Signature Polymers is to become the industry’s […]

Read More »

ExxonMobil Announces Launch of Signature Polymers

A new portfolio brand focused on delivering best-in-class service and partnership in the polymers industry SPRING, Texas, Oct. 01, 2024 (GLOBE NEWSWIRE) —  ExxonMobil today announces the introduction of Signature Polymers, a new approach to service and partnership with customers and the broader value chain. The stated brand ambition of Signature Polymers is to become the industry’s […]

Read More »

Zoom Appoints Michelle Chang as Chief Financial Officer

SAN JOSE, Calif., Oct. 01, 2024 (GLOBE NEWSWIRE) — Zoom Video Communications (NASDAQ: ZM), today announced that Michelle Chang has been appointed as its Chief Financial Officer (CFO), effective October 7, 2024. Chang brings more than 25 years of experience in financial leadership roles, most recently serving as Corporate Vice President and CFO of Microsoft’s […]

Read More »

Curium Announces Strategic Partnership with PeptiDream for Prostate Cancer Theranostics in Japan

Collaboration to include the clinical development, regulatory filing, and commercialization in Japan of 177Lu-PSMA-I&T and 64Cu-PSMA-I&T Builds on long-standing relationship between the two companies In Japan around 90,000 new cases of prostate cancer are diagnosed each year PARIS, Oct. 01, 2024 (GLOBE NEWSWIRE) — Curium, a world leader in nuclear medicine, announced today that it has entered […]

Read More »

Curium Announces Strategic Partnership with PeptiDream for Prostate Cancer Theranostics in Japan

Collaboration to include the clinical development, regulatory filing, and commercialization in Japan of 177Lu-PSMA-I&T and 64Cu-PSMA-I&T Builds on long-standing relationship between the two companies In Japan around 90,000 new cases of prostate cancer are diagnosed each year PARIS, Oct. 01, 2024 (GLOBE NEWSWIRE) — Curium, a world leader in nuclear medicine, announced today that it has entered […]

Read More »

Curium Announces Strategic Partnership with PeptiDream for Prostate Cancer Theranostics in Japan

Collaboration to include the clinical development, regulatory filing, and commercialization in Japan of 177Lu-PSMA-I&T and 64Cu-PSMA-I&T Builds on long-standing relationship between the two companies In Japan around 90,000 new cases of prostate cancer are diagnosed each year PARIS, Oct. 01, 2024 (GLOBE NEWSWIRE) — Curium, a world leader in nuclear medicine, announced today that it has entered […]

Read More »